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Blood transfusion is a fundamental therapy in numerous pathological conditions.
Regrettably, many clinical reports describe adverse transfusion’s drawbacks due to red
blood cells alterations during storage. Thus, the possibility for a blood bank to ameliorate
the quality of the erythrocyte concentrates units is crucial to improve clinical results
and reduce transfusion adverse occurrences. Leukodepletion is a pre-storage treatment
recognized to better preserve the quality of red blood cells with respect to leukoreduction.
Aim of this work is to unravel the biochemical and biophysical basis that sustain the good
clinical outcomes associated to the use of leukodepleted erythrocytes units. Erythrocytes
concentrates were prepared as leukoreduced (n = 8) and pre-storage leukodepleted
(n= 8) and then studied during 6 weeks in blood bank conditions. Overall, the data
indicate that leukodepletion not only provide red blood cells with an appropriate amount
of nutrients for a longer time but also selects red blood cells characterized by a more
resilient plasma membrane fit to prolong their viability. We believe these results will
stimulate new ideas to further optimize the current storage protocols.
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INTRODUCTION
In the past years operators in Transfusion Medicine directed particular attention toward
the standardization of donor selection, the modality of blood collection, the production of
hemocomponents and the development of tests to detect infectious agents. Among the cutting edge
themes that are now under discussion (Spitalnik et al., 2015) two of them are particularly relevant:
i. the identification and quantification of the component of each transfusion product and ii.Which
criteria must be used to match the available transfusion unit with the patient in specific clinical
scenarios. This relevant topic emerges due to the wide clinical variability of transfusion recipients,
varying from patients transfused in ambulatory to critical patients requiring multiple transfusions.
Clinical studies identified a correlation between transfusion of red blood cells (RBCs) stored
for more than 14 days and the increase of infectious events (Vamvakas and Carven, 1999;
Chang et al., 2000; Leal-Noval et al., 2001; Taylor et al., 2002), extension of hospitalization
time, prolonged mechanical ventilation, multiple organ failure (Moore et al., 1997) and mortality
(Leal-Noval et al., 2003; Gong et al., 2005). The origin of these negative outcomes are
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attributed to the morphological and biochemical modifications
that RBCs undergo during prolonged storage: e.g., the production
of lactate leads to a decrease in pH, depletion in adenosine
triphosphate and 2,3-diphosphoglycerate. A conclusive solution
to those biochemical alterations has not been found yet:
storage at low temperature (2–6◦C) slows the rate of glycolysis,
unfortunately it also decreases the activity of the Na+-K+ pump,
resulting in the alteration of electrolytes balance. The increased
K+ concentration in the conservation medium augments the risk
of arrhythmia in case of rapid transfusion through a central vein.
Storage is also known to induce changes in RBCs morphology
as well as membrane loss. In this respect, the exact correlation
between those storage lesions and the fate of the transfused
cells is still unknown and calls the attention of the scientific
community (Hess and Grazzini, 2010; D’Alessandro et al., 2012;
Dzieciatkowska et al., 2013; Prudent et al., 2015).
A subject of major debate among clinical practitioners is the
definition of the criteria for the selection of the transfusion units:
the prevalent opinion, at the moment, points to the storage time
of the bags. While there are data indicating a correlation between
RBCs storage time and morbidity/mortality of the transfused
patients (Wang et al., 2012), randomized controlled trials are in
progress to verify this fact (Steiner et al., 2010; Lacroix et al., 2011;
Alexander et al., 2016).
Consequent to these considerations, reduction of the RBCs
storage time would be a simple solution. Unfortunately, it is a
practice very difficult to be implemented in a blood bank. Thus,
methods to prolong the quality of RBCs during storage are being
searched: the removal of leukocytes, before storage, is a promising
one.
Beneficial outcomes of leukoreduction and pre-storage
leukodepletion, such as the minimization of febrile non-
hemolytic transfusion reactions; of cytomegalovirus transmission
and anti HLA immunization leading to platelet refractoriness,
are well-documented (Eisenfeld et al., 1992; Fischer et al., 1998;
Novotny et al., 1995). Other collateral effects, significantly
reduced by the introduction of this storage protocol are
post-operatory infectious complications, acute respiratory
distress syndrome (ARDS), acute lung injury (ALI), transfusion
related acute lung injury (TRALI), transfusion-associated
circulatory overload (TACO), prolonged mechanical ventilation,
hospitalization time and mortality (Bianchi et al., 2015; Silliman
et al., 2011).
Recognizing the clinical relevance of these observations,
Canada, France and UK adopted universal leukoreduction in
1990, while Germany introduced this pre-treatment in 2001.
Until end of 2015, in Italy, RBCs leukodepletion has been used
in only few centers and for specific clinical cases. In our hospital,
Arcispedale Santa Maria Nuova, Reggio Emilia, Italy, 30% of
the RBCs units were leukodepleted and used for critical patients
(intensive care unit, cardio surgery, hematology, neonatology).
Abbreviations: CPD, citrate, phosphate, dextrose; LPEC, Leukodepleted-
Pre-storage Erythrocyte Concentrate; NLPEC, Non-Leukodepleted-Pre-storage
Erythrocyte Concentrate; NMR, Nuclear Magnetic Resonance; RBCs, red blood
cells; SAGM, Saline, adenine, glucose, mannitol; WBCs, white blood cells; MCV,
mean corpuscular value; PCA, principal component analysis.
A recent decree of the Italian Ministry of Health, 2 November
2015, designated as mandatory RBCs pre-storage leukodepletion
starting January 2016.
The origin of the beneficial outcomes associated to the
introduction of RBCs leukodepletion before storage, are expected
to be due to the preservation of RBCs quality/vitality for a
longer time. Because the main difference between leukoreduced
and leukodepleted RBCs is the significantly reduced number
of leukocytes present in the bags of leukodepleted RBCs, to
progress in the optimization of RBCs storage, it is necessary
to understand how the presence of leukocytes influences RBCs
vitality, a condition that, at present, is generally associated to the
maintenance of both their proper shape and efficient metabolism.
The introduction of new “omics” methodologies such
as proteomic and metabolomics (Pertinhez et al., 2014;
D’Alessandro et al., 2015; Zolla et al., 2015; Nemkov et al., 2016)
has provided important tools to answer these questions. In this
frame, we have been prompted to study the variation of some
RBCsmorphological and biochemical parameters during storage.
We report here a comparative study on leukoreduced RBCs and
pre-storage leukodepleted RBCs.
MATERIALS AND METHODS
The study was approved by the Arcispedale Santa Maria
Nuova (ASMN) Ethics Committee on January 21, 2013. Written
informed consent was obtained from all volunteers donors who
participated in this study according to the declaration of Helsinki.
Blood components were collected from periodical donors of the
Transfusion Medicine Unit of ASMN according to the policy
of the Italian National Blood Centre Guidelines. Since our
experimental conditions did not allow to carried out a paired
study, to reduce individual variability we selected 16 males
donors aged 30–50 years.
Blood Collection and Processing
Sixteen whole blood units (450mL ± 10%) were collected
using the top-and-bottom system (Fresenius Kabi Medicare
Bad Homburg, Germany). Eight were collected into triple bags,
and eight into quadruple bags, containing Citrate, Phosphate,
Dextrose solution (CPD). All the units were centrifuged by
Hettich Roto Silenta 630 RS centrifuge (22◦C, 11 min, 4000 ×
g) therefore, most of the plasma and buffy coat was removed
using a Compomat G4 separator (Fresenius Kabi Medicare)
and RBCs were stored in 100mL of saline, adenine, glucose
and mannitol (SAGM) additive solution. Those collected into
triple bags were prepared as Non-Leukodepleted Erythrocyte
Concentrate (NLPEC) while the ones collected in the quadruple
bags were prepared as Leukodepleted Prestorage Erythrocyte
Concentrate (LPEC) using in-line filters.
After 24 h, each RBC unit was divided in 7 satellites bags of
40mL each (Fresenius Kabi Medicare Bad Homburg, Germany).
Satellite bags were stored under standard conditions (2–6◦C) and
analyzed at different Day (2, 9, 16, 23, 30, 36, and 42) of storage.
An aliquot from each bag was taken for cell count, hematocrit,
mean corpuscular value (MCV) and total hemoglobin
determination (Sapphire instrument Abbott diagnostic Illinois,
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USA and Cytomix FC 500 Beckman Coulter IL, Indianapolis,
USA). A residual number of leukocytes (<< 1 × 106 a depletion
of log 4) were present in the final LPEC units according to the
Italian Blood National System regulatory law.
Definition of NLPEC and LPEC
NLPEC = buffy-coat poor RBCs = leukoreduced RBCs (0.95 ±
0.39× 109 WBCs per unit, n= 8).
LPEC = buffy-coat removal + leukofiltration = highly
depleted or leukodepleted RBCs, according to EU guidelines<<
1× 106 WBCs (a depletion of log 4) per unit.
RBCs Supernatant and RBC Lysate
Preparation
The RBCs supernatant was collected after centrifugation at 2000
× g for 10min andwas divided into two aliquots. One aliquot was
used without further modifications for biochemical assays (see
below) while the other was depleted of proteins by ultra-filtration
(5000 Da cut-off) and frozen at −80◦C for subsequent 1H-NMR
measurements.
RBCs lysate was prepared as follow: red blood cells were
washed twice by suspension in 0.9% NaCl in 5mM phosphate
buffer pH 7.4 followed by centrifugation at 2000 g× 10 min. The
collected RBCs were then lysed through two cycles of freezing in
liquid nitrogen and thawing at 37◦C followed by sonication for
30 s. Proteins and membranes were eliminated by ultra-filtration
(cut-off 5000 Da), as described in Pertinhez et al. (2014).
Supernatant Biochemical Assays
Supernatant: Na+ and K+ were measured by an indirect
ion-selective electrode method (Hoffmann-La Roche Ltd).
Total proteins, lactate and lactate dehydrogenase (LDH), were
measured by Cobas© Roche.
RBCs hemolysis was evaluated by the absorption spectrum of
free hemoglobin (HbO2), using an extinction coefficient of 512
mM−1cm−1 at 415 nm on a spectrophotometer JASCO V-630.
1H-NMR Experiments
Samples were prepared by mixing 570 microliters of the ultra-
filtrate either of the RBCs supernatant or of the RBCs lysate, with
30 microliters of TSP (1% in D2O) and 10 microliters of 1 M
phosphate buffer pH 7.4 (Pertinhez et al., 2014).
1D 1H-NMR spectra were acquired at 25◦C on a Spectrometer
Varian Inova 600MHz (Palo Alto, USA); processing and peaks
assignment was performed with Chenomx NMR suite 7.6
(Edmonton, Canada) as previously described in Pertinhez et al.
(2014). The 1H-NMR spectra were automatically reduced into
consecutive integrated spectral regions (buckets) of an equal
width (0.03 ppm). The region containing the water resonance
(4.5–5.0 ppm) was not included in the analysis.
Statistical Analysis
Significance has been evaluated by two-way ANOVA tests
followed by Fisher LSD post hoc tests. P-values smaller than 0.05
were considered to be significant.
MestReNova 8.1 software (Santiago de Compostela, Spain)
was used to perform the principal component analysis (PCA).
FIGURE 1 | Mean Corpuscular Value (fL) of RBC during storage: LPEC
( ) linear fit r = 0.96; NLPEC ( ) sigmoidal fit r2 = 0.95 Chi2 = 0.137.
ANOVA showed a significant effect for both the storage time and preparation
(p < 0.0005). Interaction between variables was not significant. Post hoc tests
indicated always significant differences at each storage time between
preparations (p < 0.05).
Prior to multivariate statistic, pareto scaling, which scales data
by dividing each variable by the square root of the standard
deviation, was applied.
Note that metabolites concentration were measured starting
from the 2nd day of conservation (that therefore is our initial
time, t1), after mandatory tests performed by the Transfusion
Medicine Unit in accordance with the Transfusion Regulatory
Italian law (n◦ 219, 21 October 2005).
RESULTS
RBCs Mean Corpuscular Value during
Storage
Under physiological conditions, RBCs lifespan is 120 days: their
aging in vivo is associated to a decrease in volume and an increase
in cell density (Bosman, 2013). In blood bank conditions,
instead, after the removal of plasma and buffy coat, and re-
suspension in SAGM, we observe that RBCs, irrespective of being
leukodepleted or not, increase their Mean Corpuscular Value
(MCV) during storage (Figure 1).
Note that, in the 16 whole blood freshly collected units, the
RBCs showed an initial similar MCV of 85.5 fL ± 2.95 and
the MCV values remained within the laboratory reference range
(80-100 fL), for both preparations, throughout the storage time.
Nonetheless, Figure 1 shows that NLPEC MCV undergoes a
higher increase with respect to LPEC MCV. The increase of red
blood cells MCV, which we measure in SAGM, is consistent with
the current data (Veale et al., 2011).
The different behavior between NLPEC and LPEC is already
evident at time 1, Day 2, (p = 0.011) and it becomes more
significant at Day 42 (p = 0.006). The linear increment (r =
0.96) of the MCV values measured for LPEC, as compared to
the NLPEC units, that exhibits a sigmoidal behavior (r2 =
0.95), suggests that leukodepletion selects a homogeneous RBCs
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FIGURE 2 | Hb and LDH in the supernatant of LPEC and NLPEC during
storage. (A) Changes in Hb concentration: LPEC ( ), NLPEC ( ). ANOVA
showed a significant main effect of storage time (p < 0.0005) and significant
interaction between storage time and preparation (p = 0.0002) (B) Fold
increase comparison: LPEC LDH ( ) and Hb ( ), NLPEC LDH ( ) and Hb ( ).
population. In particular, we hypothesize that leukodepleted
RBCs are characterized by a higher deformability that would
favor their passage through the filter and are more resistant to
cell volume impairment during storage.
Changes in Free Hb and Lactate
Dehydrogenase (LDH) Concentrations
The free hemoglobin content in the supernatant progressively
increases over time for both preparation (Figure 2). This is
expected to be the consequence of aging and death of the blood
cells with consequent release of the intracellular content in the
conservation medium. ANOVA reveals that free hemoglobin
concentration is not significantly influenced by preparation
(LPEC or NLPEC) but by a combined effect of storage time and
preparation. Interestingly, as reported in Figure 2A, in the initial
20 days of storage, NLPEC (Hb = 2.8 µM, Day 2) exhibit a free
hemoglobin content that is regularly lower than in LPEC (Hb =
7.9 µM, Day 2); a fact that we attribute to the consequence of
leukodepletion, i.e., to the mechanical damage that some blood
cells suffer passing through the sieve. However, after Day 20, the
FIGURE 3 | Electrolytes concentration. K+: LPEC ( ), NLPEC ( ). Na+:
LPEC ( ) NLPEC ( ). Normal ranges are marked in green for K+, in magenta
for Na+. ANOVA showed a significant effect of storage time (p < 0.0005) for
both ions. Interaction between variables is not significant. Post hoc-tests
between storage times of the same preparation were always significant (p <
0.05) both for LPEC and NLPEC.
trend is reversed and LPEC exhibit a reduced degree of hemolysis,
proving that the leukodepleted RBCs are more resistant to the
osmotic changes experienced during storage.
To remove any possible bias, data were normalized to the
values measured at time 1, Day 2 (see Material and Methods).
Figure 2B shows a higher free Hb content in the NLPEC units
since the beginning of storage. More than that, in the case of
LPEC units, the increment of free hemoglobin is clearly reduced
throughout the storage time. The fact that the variation in free
Hb is associated to the release of the intracellular enzyme LDH,
a marker of cellular damage, assures that we are observing
the result of cells’ aging and death with subsequent lysis. The
correlation between Hb and LDH increase is good in both
preparation, LPEC and NLPEC (r = 0.93 and 0.97, respectively).
Electrolytes (K+/Na+) Concentration in the
Supernantant during Storage
Figure 3 shows that for both LPEC and NLPEC the K+ and Na+
concentration in their supernatant changes across storage period
with same trend and extension: K+ concentration increases up to
∼50 mM at Day 42, while the Na+ concentration exhibits a 26%
decrease. Our data are consistent with the values reported in the
literature and, as generally accepted, result from the low storage
temperature.
Proteins and Free Amino Acids
The supernatant of leukodepleted RBCs exhibits a significantly
reduced total proteins content with respect to non-leukodepleted,
since Day 2, (p < 0.0001), with a 1-reduction of about 0.4 g/dL
maintained over time (Figure 4A). Indeed, in the case of LPEC
part of the residual plasma proteins are expected to be filtered
out. During storage, an increase of the total protein content is
observed in both preparations (≈0.2 g/dL, p < 0.001, Day 2 vs.
Day 42).
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FIGURE 4 | (A). Protein content. ANOVA showed significance (p < 0.0005) for
both storage time and preparation. Interaction between variables is not
significant. LPEC vs. NLPEC comparison at each storage time is always
significant (p < 0.0001). (B) Free amino acids quantification, in the
supernatant, during storage. LPEC (red bar) vs. NLPEC (blue bar)
comparisons at each storage time addressed all amino acids concentrations
significantly higher (p < 0.05) in NLPEC units from Day 21.
Using 1H-NMR spectroscopy, we have been able to identify
11 free amino acids (Gly, Ala, Gln, Phe, His, Tyr, Trp, Leu,
Ile, Val, Lys) in the supernatants. Two-way ANOVA indicated
a significant effect of both storage time and preparation (p <
0.0005) over amino acids concentrations. Ala, Gln, Val and
Lys starting from Day 21 (Figure 4B) were always significantly
higher in NLPEC (p < 0.05). As for the other amino acids,
instead, we found a significant higher concentration in NLPEC
(p < 0.05) starting either from Day 28 or Day 36 (data not
shown). These results suggest that in the NLPEC units the
extent of cell lysis throughout the storage time is constantly
higher than in LPEC. This event leads to a concentration of
proteases that is progressively higher in the NLPEC units than
in LPEC and, therefore, to an enhanced protein degradation in
the NLPEC units: note that during storage WBCs number, in
NLPEC, decreases from 0.95 × 109/unit at Day 2 to 0.32 ×
109/unit at Day 42.
FIGURE 5 | SAGM additives quantification during storage. The
concentrations are normalized to the Day 2. LPEC ( ) and NLPEC ( ).
Variation of Additives Concentration in the
Storage Medium
Figure 5 reports the variation, during storage, of the
concentrations of SAGM components measured by 1H-
NMR. Citrate concentration is stable and comparable, over
time, in both NLPEC and LPEC samples as previously reported
(Pertinhez et al., 2014). Gevi et al. (2012) reported that in RBCs,
stored in SAGM, mannitol decreases overtime. Our results reveal
a slight decrease of mannitol concentration in LPEC. Knowing
that mannitol is not metabolized, this result points to a facilitated
diffusion of this additive inside leukodepleted RBCs.
In NLPEC samples we measure a faster decrease of adenine
concentration, this behavior being prominent in the initial 15
days. We interpret this trend as the result of the competition of
WBCs and platelets with RBCs for that metabolite that is essential
to produce ATP. After Day 15 when apparentlymost of those cells
begins to lyse, as we inferred from the increase of the protein and
free amino acid content in the supernatant (see above), the rate
of adenine consumption equalizes between the two preparations.
As for glucose consumption, Figure 5 shows it is comparable
in both preparations. This result, that at first glance appears
contradictory with the trend of adenine depletion, can be
rationalized if we recall that in SAGM, the concentrations of
glucose (45.4mM) and adenine (1.25mM) are quite different,
and that the number of WBCs and platelets is considerably
smaller than the number of RBCs. Therefore, considering the
dynamic range of our measurements, the metabolic activity of
WBCs and platelets results more evident when measuring the
variation of adenine concentration with respect to the extent of
glucose variation.
Overall, these results clearly indicate a negative effect of the
presence of WBCs and platelets on RBCs viability during the
storage time, as they significantly reduce adenine concentration
that turns out to be a limiting factor. In fact, a significant
difference is observed through the first 21 days (p ≤ 0.005).
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Metabolites Concentration in RBC Lysates
Table 1S reports a list of the 39 identified metabolites in
RBC lysates and their concentrations on Days 2 and 42,
for both preparations. A one-way ANOVA was performed to
highlight which metabolites were influenced by preparation:
12 compounds presented p < 0.005 (Table 1). At Day 2,
LPEC present a higher concentration of adenine, citrate,
mannitol, and glucose. Alanine and urea, instead, are present
TABLE 1 | Metabolites identified on RBCs lysates of NLPEC and LPEC.
Concentration as reported as mean ± SD at Day 2 and Day 42.
Metabolite NLPEC (mM) LPEC (mM)
Day 2 Day 42 Day 2 Day 42
Adenine* 0.119± 0.004 0.009± 0.006 0.220±0.073 0.017±0.024
Alanine* 0.388± 0.078 0.426± 0.073 0.309±0.031 0.340±0.045
AMP 0.140± 0.059 0.476± 0.160 0.137±0.035 0.188±0.048
ATP 1.228± 0.184 0.217± 0.093 1.425±0.218 0.445±0.089
Citrate* 0.017± 0.020 0.020± 0.011 0.056±0.042 0.036±0.022
Glucose* 6.319± 1.565 3.235± 1.105 11.960±3.897 3.405±1.069
Glutathione 2.378± 0.426 1.365± 0.165 2.692±0.533 1.981±0.529
Hypoxanthine 0.015± 0.001 0.393± 0.131 0.017±0.025 0.280±0.056
IMP 0.106± 0.038 0.145± 0.036 0.082±0.020 0.104±0.029
Mannitol* 0.324± 0.121 1.421± 0.486 0.483±0.019 2.222±0.261
5-oxoproline 0.086± 0.027 0.710± 0.064 0.076±0.031 0.646±0.031
Urea* 0.459± 0.120 1.005± 0.298 0.238±0.113 0.490±0.124
Metabolites were significantly affected by preparation (ANOVA, p< 0.005). Post hoc tests
were performed. In red are highlighted the metabolites whose concentrations at Day 42
are significantly different (p< 0.05) between NLPEC and LPEC. *indicates the metabolites
that significantly different (p < 0.05) at Day 2 between both preparations.
at lower concentration. Before any handling, the RBCs cytosolic
concentration of those molecules, with respect to SAGM, is lower
for adenine, citrate, mannitol and glucose and higher for alanine
and urea; we interpret the data obtained for LPEC at Day 2 as
the result of filtration. In fact during filtration, it is reasonable
to expect that the perturbation of the membrane organization
may enhance its osmotic permeability favoring the intake of the
SAGM components, and the exit of the cytosolic metabolites.
Similarly, we observed significant differences of the cytosolic
concentration of some metabolite (p < 0.05), at Day 42. The
ATP concentration in NLPEC samples is almost 50% lower with
respect to LPEC, while purine’s degradation catabolites, AMP,
IMP and hypoxanthine show increased concentrations (2.5 fold
AMP and 1.4 fold IMP and hypoxanthine). In addition, in
NLPEC a decrease of glutathione (GSH) is accompanied by an
increase of 5-oxoproline, thus pointing to the possibility that,
during storage, non-leukodepleted RBCs are more keen to suffer
a reduction of their antioxidant defenses, (Pertinhez et al., 2014).
Chemometric Analysis of RBC Lysates
As described in previous works (Pertinhez et al., 2014; Casali
et al., 2015), using 1H-NMR spectroscopy we identified a number
of metabolites in the suspension medium of LPEC. However,
due to the high concentration of the additives, as well as of
the lactate produced by the cells during storage, that covered a
wide region of the 1H-NMR spectra, the Principal Component
Analysis (PCA) of the supernatants composition could not be
carried out. The PCA was then performed on LPEC and NLPEC
lysates (Figure 6).
The first principal component (PC1) accounts for 63.3% of
the total variation in the dataset and well separate LPEC (orange
to violet symbols) from NLPEC (light to dark blue symbols).
FIGURE 6 | Chemometric analysis of RBC lysates samples. The score plot reports NLPEC samples (light to dark blue symbols) and LPEC (orange to violet
symbols). PC1 separates on the x axis the two preparations with the major contribution of glucose, lactate and alanine. Mannitol, ATP and GSH contribute to PC2,
that on the y axis separate each preparations by day of storage.
Frontiers in Molecular Biosciences | www.frontiersin.org 6 April 2016 | Volume 3 | Article 13
Pertinhez et al. RBCs Leukoreduction vs. Leukodepletion
FIGURE 7 | NMR quantification of the major contributors to PCA plot:
(A) Glucose. ANOVA indicated significant interaction between storage time
and preparation (p < 0.001) as well as a significant effect of both variables
alone (p < 0.0005). Post hoc tests showed higher concentration of glucose in
LPEC from Day 2 to Day 36 (p < 0.05). (B) Mannitol. Storage time and
preparation affect independently mannitol concentration (p < 0.0005 for both
variables). *indicate p < 0.05 when comparing each storage time with the
following one, in both preparations. Samples NLPEC ( ), LPEC ( ).
Glucose is the major contributor to PC1 together with alanine
and lactate that however exert a minor influence (data not
shown).
PC2 accounts for 11.6% of the discrimination among RBCs
content and allows to evaluate the changes that occur in the
metabolites present in the cytoplasm during the storage. The
separation of RBCs as a function of their age is particularly
evident for LPEC (Figure 6, right side). Mannitol turns out to be
the major contributor to PC2, with ATP and GSH as additional
factors. The ability of mannitol to discriminate RBCs during
storage is confirmed by t-student’s p-values obtained for both
LPEC and NLPEC, when comparing each storage time with the
following one of samples belonging to the same preparation. This
is particularly evident between Days 2, 9, and 16 (Figure 7B).
The wide spread produced by PC2 only for LPEC supports the
idea that filtration selects RBCs with similar morphological and
biochemical features and that exhibit a comparable aging trend.
Figures 7A,B complement the PCA and allow to better
understand the metabolic evolution of NLPEC and LPEC over
time. Figure 7A shows that in LPEC, glucose concentration
is significantly higher (p < 0.01) than in NLPEC, throughout
storage, except for Day 42. Interestingly however, while in the
initial 9 days of storage LPEC presents a concentration of glucose
that is twice as much the one present inside NLPEC, from Day
14 throughout Day 36 the difference reduces to about 30% and
equalize at Day 42. Overall these data support the hypothesis
outlined above that filtration favors an initial burst of glucose
uptake. Figure 7B shows that mannitol diffusion inside RBCs
proceed more effectively in LPEC than in NLPEC throughout the
storage time, consistently with the decrease of its concentration
measured in the supernatant (Figure 5). All these data support
the hypothesis that leukodepleted RBCs are characterized by a
plasma membrane that preserve, for a longer time, its integrity, a
fact compatible with their longer viability.
DISCUSSION
RBCs modifications over time are well-recognized to be one
of the factors responsible for the negative outcomes associated
to blood transfusion therapy (Sparrow, 2015). Thus, there is a
stringent need to improve the protocols used to prepare RBCs
concentrates for blood banks. Nowadays, around the world, both
leukoreduction and leukodepletion are accepted as pre-storage
protocols as they appears to prolong the viability/quality of
RBCs units. A recent decree of the Italian Ministry of Health
forces all Italian blood transfusion centers to include pre-storage
leukodepletion in the preparation of RBCs concentrates. Because
the scientific basis of the good clinical results obtained by
reducing the number of leukocytes and platelets in the RBCs
units to be stored is still matter of debate, and considering
that leukodepletion is a more expensive protocol, we have been
prompted to seek the biophysical/biochemical motivations that
may justify that choice. Answering those questions will allow to
devise a rationale improvement of the current storage protocols.
To tackle this issue we chose NMR spectroscopy in
combination with standard biochemical (Gallo et al., 2015).
Overall we have been able to follow the consumption of the
additives necessary to RBCs survival, even in the presence of
their high concentration we identified more than 30 metabolites
in the supernatant, and 39 metabolites in the lysates RBCs.
Interestingly, some of our data were confirmed by MS in the
RBCs additive solution AS-3 (D’Alessandro et al., 2015).
Our results highlighted that leukodepletion, differently from
leukoreduction: i) selects a homogeneous population of RBCs
characterized by a healthier and more deformable plasma
membrane that assures a prolonged viability. The stress due
to filtration destroys the not perfectly fit RBCs, as revealed by
the high hemolysis measured at Day 2 (Figure 2) and favors a
burst of glucose uptake by the healthy RBCs (Figure 7A) able
to pass through the filter. ii) by removing WBCs and platelets
provides RBCs with an appropriate concentration of nutrients for
a longer time (Figure 5). The removal of WBCs and platelets is
particularly relevant with respect to the consumption of adenine
that in NLPEC turns out to be a limiting factor for cells viability
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particularly after Day 28 (Figure 5). Indeed, recognizing that to
preserve the RBCs energy requirement, the adenine nucleotide
pool, under homeostatic conditions, it requires approximately
2 mM ATP, 0.1 mM ADP, and 0.04mM AMP (Gibson and
Harris, 2002), if we estimate the adenine nucleotide pool in
NLPEC and LPEC toward the end of the allowed storage
time, based on the data reported in Table 1 and Table 1S,
we find that LPEC better preserve the adenine nucleotides
balance.
The PCA shows also that while the spread of LPEC determined
by PC1 is limited, NLPEC are distributed over a wider range of
values. Moreover, if we consider the PC2 component we observe
it clearly separates LPEC according to their age, while it has
practically no effect on NLPEC. This result further confirms the
fact that filtration generates a homogeneous population of RBCs
evolving uniformly in time.
We feel these results, per se, might already justify the
advantage of pre-storage leukodepletion over leukoreduction.
In addition we found that the NLPEC suspension medium
presents a higher concentration of free amino acids, especially on
late storage times (Figure 4B) that, together with the associated
higher proteins’ content (Figure 4A), suggests the presence of
proteases released by dead blood cells. It is worth noting that
reduction of proteins and proteins derivatives in the RBCs
units, as it occurs in LPEC, may also reduce unexpected
immunoreaction in transfused patients.
In summary, our biochemical and biophysical data point to
pre-storage leukodepletion as an appropriate and preferable, with
respect to leukoreduction, protocol to preserve the quality of the
RBCs over time.
We believe this more in depth vision of the behavior of
leukoreduced and leukodepleted RBCs, during storage in blood
bank conditions, will stimulate new ideas to further optimize
storage protocols.
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